| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Thioridazine hydrochloride |
Is a |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Thioridazine poisoning |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental thioridazine poisoning |
Causative agent (attribute) |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Intentional thioridazine poisoning |
Causative agent (attribute) |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Thioridazine poisoning of undetermined intent |
Causative agent (attribute) |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to thioridazine (finding) |
Causative agent (attribute) |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Thioridazine overdose |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental thioridazine overdose |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Intentional thioridazine overdose |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine overdose of undetermined intent |
Causative agent (attribute) |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine 10mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Thioridazine 50mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely thioridazine 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely thioridazine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely thioridazine (as thioridazine hydrochloride) 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Product containing thioridazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine 100mg/mL oral concentrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Thioridazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine measurement (procedure) |
Component |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Accidental thioridazine poisoning |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Intentional thioridazine poisoning |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine adverse reaction |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine retinopathy |
Causative agent (attribute) |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Allergy to thioridazine (finding) |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Thioridazine 50mg/5mL conventional release oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely thioridazine (as thioridazine hydrochloride) 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thioridazine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely thioridazine 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely thioridazine 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely thioridazine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely thioridazine 20 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely thioridazine (as thioridazine hydrochloride) 5 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only thioridazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely thioridazine (as thioridazine hydrochloride) 100 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine 2 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine 2 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine 30 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine 30 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
| Thioridazine retinopathy |
Causative agent (attribute) |
True |
Thioridazine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]